Responses after one dose of a monovalent influenza A (H1N1) 2009 inactivated vaccine in Chinese population--a practical observation (Q30404997)

21 June 2017

title

Responses after one dose of a monovalent influenza A (H1N1) 2009 inactivated vaccine in Chinese population--a practical observation (English)

1 reference

21 June 2017

Fuyan Sun

1 reference

21 June 2017

Yunzhi Zhang

1 reference

21 June 2017

Di Tian

1 reference

21 June 2017

Min Zheng

1 reference

21 June 2017

Li Liu

1 reference

21 June 2017

Renfang Zhang

1 reference

21 June 2017

Zhengsheng Dai

1 reference

21 June 2017

Jun Chen

1 reference

21 June 2017

Tingting Li

1 reference

21 June 2017

Hongzhou Lu

1 reference

21 June 2017

language of work or name

English

0 references

publication date

19 July 2011

1 reference

21 June 2017

1 reference

21 June 2017

1 reference

21 June 2017

1 reference

21 June 2017

page(s)

6527-6531

1 reference

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Response to a monovalent 2009 influenza A (H1N1) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

A novel influenza A (H1N1) vaccine in various age groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

A cell-microelectronic sensing technique for profiling cytotoxicity of chemicals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.006

10.1016/J.VACCINE.2011.07.006

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference